Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and H20223350.
Reprint statement: reprint please indicate "source: Wista pharma".
86-10-67887855
Head Office：5F, Building No.6, HAN's Enterprise Bay, Liangshuihe No.2 Street, Beijing Economic Technological Development Area, Beijing, 100176, P.R.China
Marketing：sales@51cns.com
R&D Department：RD@51cns.com
Wista Pharmam
简体中文
